Search clinical trials for: DLB
Total 636 results
-
CelgeneCompletedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinFrance, Italy, Netherlands
-
Regeneron PharmaceuticalsCompletedDiffuse Large B-Cell LymphomaAustria, France, Germany, United Kingdom
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingDLBCL | Large B-cell LymphomaUnited States
-
Hoffmann-La RocheCompletedLymphoma, Large B-Cell, DiffuseChina
-
Philogen S.p.A.Terminated
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy
-
University Hospital Southampton NHS Foundation...CompletedNon Hodgkin LymphomaUnited Kingdom
-
The Lymphoma Academic Research OrganisationActive, not recruitingAggressive Non-Hodgkin LymphomaFrance, Belgium
-
Chengdu Zenitar Biomedical Technology Co., LtdCompletedDiffuse Large B Cell Lymphoma，DLBCLChina
-
Prof. Dr. Clemens SchmittCharite University, Berlin, Germany; Janssen-Cilag Ltd.Active, not recruitingDiffuse Large B Cell LymphomaGermany
-
Hackensack Meridian HealthCelgene CorporationCompletedDiffuse Large B Cell LymphomaUnited States
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
Sun Yat-sen UniversityCompletedLymphoma, Large B-Cell, DiffuseChina
-
Dexa Medica GroupBinawaluya Cardiac HospitalTerminatedST Elevation Myocardial InfarctionIndonesia
-
Regeneron PharmaceuticalsActive, not recruitingChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, United Kingdom, Israel, Germany, France
-
Chipscreen Biosciences, Ltd.Active, not recruitingDiffuse Large B-cell LymphomaChina
-
Peter MacCallum Cancer Centre, AustraliaHoffmann-La RocheActive, not recruitingDiffuse Large B Cell Lymphoma | High-grade B-cell LymphomaAustralia
-
Stichting Hemato-Oncologie voor Volwassenen NederlandActive, not recruitingNHL | DLBCLNetherlands, Belgium
-
Incyte CorporationCompleted
-
Patrick ReaganSeagen Inc.Active, not recruitingDiffuse Large B-Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCCompletedHodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T-Cell LymphomaUnited States
-
Cyteir Therapeutics, Inc.Active, not recruitingSoft Tissue Sarcoma | Follicular Lymphoma | Breast Cancer | Head and Neck Cancer | Small Cell Lung Cancer | Multiple Myeloma | Pancreatic Cancer | Ovarian Cancer | Mantle Cell Lymphoma | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | DLBCL | Non-hodgkin Lymphoma | Malignancy | CLLUnited States
-
ExelixisTerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Non-Hodgkin's Lymphoma (NHL) | Mantle Cell Lymphoma (MCL) | Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL)United States
-
Regeneron PharmaceuticalsAvailableDiffuse Large B-Cell Lymphoma (DLBCL) | Relapsed or Refractory (R/R) Follicular Lymphoma (FL) | B-Cell Non-Hodgkin Lymphoma (NHL) | High-Grade B-Cell Lymphoma (HGBCL)
-
Memorial Sloan Kettering Cancer CenterSanofi; Columbia University; Medical College of Wisconsin; University of Rochester and other collaboratorsActive, not recruitingDiffuse Large B-cell Lymphoma (DLBCL) | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)United States
-
Eisai Co., Ltd.CompletedDementia With Lewy Bodies (DLB)Japan
-
Sierra Oncology LLC - a GSK companyCompletedLymphoma, Diffuse Large B-CellUnited States, Puerto Rico
-
EIP Pharma IncWorldwide Clinical TrialsCompletedDementia With Lewy Bodies (DLB)United States, Netherlands
-
Sierra Oncology LLC - a GSK companyTerminatedRichter's TransformationUnited States
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaUnited States
-
CelgeneCompletedLymphoma, Large B-Cell, DiffuseUnited States, Australia, Belgium, Canada, China, Czechia, France, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Portugal, Puerto Rico, Russian Federation, Spain, Switzerland, Taiwan, Turkey
-
Asana BioSciencesTerminatedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Cancer | Lymphoma, Malignant | Myelofibrosis | Lymphoma, Mantle-Cell | Chronic Lymphocytic Leukemia | Peripheral T-Cell Lymphoma | Tumor | Neoplasm | B-Cell Chronic Lymphocytic Leukemia | Leukemia, Lymphocytic, Chronic | Idiopathic Myelofibrosis and other conditionsUnited States, Argentina
-
Epizyme, Inc.CompletedSolid Tumor | Mesothelioma | Rhabdoid Tumor | Hematologic Malignancy | Advanced Malignancies | Synovial Sarcoma | Renal Medullary Carcinoma | Diffuse Large B-Cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Non-Hodgkin Lymphoma (NHL) | All Malignancies | Epithelioid Sarcoma (ES)Spain, United States
-
GenmabAbbVieApproved for marketingPrimary Mediastinal Large B-cell Lymphoma (PMBCL) | Large B-cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-cell Lymphoma (HGBCL) | Grade 3B Follicular Lymphoma
-
CelgeneCompletedLymphoma, Large B-Cell, DiffuseUnited States, Austria, United Kingdom, Estonia, Denmark
-
University of AarhusCompletedDementia With Lewy Bodies | Positron-Emission Tomography | Degeneration Nerves | AcetylcholineDenmark
-
University Medical Center GroningenHoffmann-La Roche; Amsterdam UMC, location VUmc; Stichting Hemato-Oncologie voor...WithdrawnDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedNetherlands
-
MEI Pharma, Inc.TerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone B Cell Lymphoma | High Grade Non-Hodgkin's LymphomaUnited States, Switzerland
-
Sorrento Therapeutics, Inc.WithdrawnDiffuse Large B Cell Lymphoma | Biliary Tract Cancer | Peripheral T Cell Lymphoma | Extranodal NK T Cell Lymphoma, Nasal
-
University College, LondonCompletedDiffuse Large B-Cell LymphomaUnited Kingdom
-
Tessa TherapeuticsActive, not recruitingAnaplastic Large Cell Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL)United States
-
SymBio PharmaceuticalsCompletedAssess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCLJapan
-
SymBio PharmaceuticalsCompletedDiffuse Large B Cell LymphomaJapan
-
Calithera Biosciences, IncTerminatedNon-GCB/ABC Diffuse Large B-Cell Lymphoma | With and Without MyD88 and/or CD79B MutationsUnited States
-
Antengene CorporationActive, not recruitingRelapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)China
-
Sarit AssoulineNovartis; Hoffmann-La Roche; Quebec Clinical Research Organization in CancerCompletedDiffuse Large B Cell LymphomaCanada
-
The Lymphoma Academic Research OrganisationEpizyme, Inc.Active, not recruitingLymphoma | Follicular Lymphoma | DLBCLFrance, Belgium
-
Antengene CorporationTerminatedRelapsed/Refractory Diffuse Large B-cell LymphomaChina
-
The Lymphoma Academic Research OrganisationCompletedFollicular Lymphoma Patients (Phase IB) | Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)France, Belgium
-
MorphoSys AGCompletedDiffuse Large B-cell LymphomaBelgium, Germany, United States, Austria, Czechia, France, Italy, Portugal, Spain